The global Infection Control Market reached a valuation of USD 214.0 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. A primary catalyst for this market expansion is the escalating volume of surgical and clinical procedures, which inherently necessitate robust infection prevention measures. This preference for infection control is likely due to the demonstrable positive clinical outcomes associated with its implementation. Furthermore, the COVID-19 pandemic significantly boosted market growth, leading to a surge in demand for sterilization and disinfection solutions across hospitals, clinics, pharmaceutical companies, and medical device manufacturers.

The potential for continued growth in infection control products is evident; for example, CNBC reported a 60% increase in sanitizer product manufacturing in the U.S. alone during the pandemic. The market is also benefiting from a rise in outsourced sterilization services and the introduction of innovative sterilizing solutions. A crucial driver of growth is the growing number of government initiatives aimed at ensuring highly effective infection prevention.

Detailed Segmentation:

Type Insights

Based on type, the services segment is expected to grow at the fastest CAGR during the forecast period. This fastest growth is attributed to the high inclination of market players to reduce overall healthcare expenditure and the utilization of benefits involved. It primarily includes cost advantages, increased efficiency of services, enhanced productivity, and a significantly higher focus on the core areas of development, which are critical to a company’s overall profit and growth. The organizations also strive to promote the adoption through issuing guidelines and recommendations for selection, risk assessment, rational usage, removal, and considerations to reduce the risk of transmission of respiratory pathogens to healthcare workers and other medical staff within a healthcare facility.

End-use Insights

Based on end use, the global infection control market is segmented into medical device companies, hospitals, pharmaceutical companies, clinical laboratories, and others. The hospital segment dominated the market for infection control and accounted for the largest revenue share of around 40% in 2022 and is also expected to grow at the fastest CAGR of 7.4% over the forecast period from 2023 to 2030. The considerable share is majorly a result of the high probability of getting infected on hospital premises by transmitting blood-borne or respiratory pathogens.

Regional Insights

Asia Pacific is expected to expand at the fastest CAGR of 8.3% over the forecast period from 2023 to 2030, owing to the growing number of outsourcing organizations, growing expenditure on healthcare, and evolving healthcare standards and infrastructure unprecedently across this region. Government organizations are focusing more on improving infection control standards as it is also one of the important factors contributing to the growth of the Asia Pacific region.

Gather more insights about the market drivers, restraints, and growth of the Infection Control Market